Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $295.0000 (-4.84%) ($290.0000 - $337.5000) on Mon. Jun. 13, 2011. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.31% (three month average) | RSI | 53 | Latest Price | $295.0000(-4.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -3.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(4%) EWP(3%) IWM(3%) XOP(3%) EWI(2%) | Factors Impacting CAPR price | CAPR will decline at least -3.655% in a week (0% probabilities). REMX(-1%) IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.655% (StdDev 7.31%) | Hourly BBV | 0 () | Intraday Trend | -0.8% | | | |
|
Resistance Level | $304.53 | 5 Day Moving Average | $302.5(-2.48%) | 10 Day Moving Average | $302.12(-2.36%) | 20 Day Moving Average | $304.53(-3.13%) | To recent high | -32.9% | To recent low | 6.5% | Market Cap | $5.811b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |